Lippoldt Darin: insider trades.
Lippoldt Darin reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($1.8M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Lippoldt Darin
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Officer · Chief Legal Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Neurocrine Biosciences Inc | F | 2,419 | $156.22 | 56,793 | Form 4 |
| 2026-09-11 | Neurocrine Biosciences Inc | A | 4,483 | $0 | 59,212 | Form 4 |
| 2026-07-09 | Neurocrine Biosciences Inc | M | 10,000 | $81.49 | 64,729 | Form 4 |
| 2026-07-09 | Neurocrine Biosciences Inc | S | 10,000 | $179.6 | 54,729 | Form 4 |
Questions
What stock did Lippoldt Darin buy or sell?
Lippoldt Darin reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($1.8M), across 1 company.
Is Lippoldt Darin the same person as other filers with this name?
This page covers SEC CIK 1504783 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lippoldt-darin-1504783.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.